Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeev Shukla

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cancer Letters|March 23, 2020
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cellsSimona Camero, Lucrezia Camicia, Francesco Marampon, et al.
Oncology Reports|June 7, 2017
A sketch of known and novel MYCN-associated miRNA networks in neuroblastomaFrancesca Megiorni, Moreno Colaiacovo, Samantha Cialfi, et al.
Journal of Cancer Research and Clinical Oncology|October 26, 2018
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell linesSimona Camero, Simona Ceccarelli, Francesca De Felice, et al.
Eclinicalmedicine|April 25, 2022
SARS-COV2 placentitis and pregnancy outcome: A multicentre experience during the Alpha and early Delta waves of coronavirus pandemic in EnglandSophie Stenton, Jo McPartland, Rajeev Shukla, et al.
Journal of Hematology & Oncology|October 8, 2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cellsFrancesca Megiorni, Giovanni Luca Gravina, Simona Camero, et al.
Frontiers in Pediatrics|August 8, 2022
Thyroid cancer in children: A multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumorsCristina Martucci, Alessandro Crocoli, Maria Debora De Pasquale, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cancer Letters|March 23, 2020
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cellsSimona Camero, Lucrezia Camicia, Francesco Marampon, et al.
Oncology Reports|June 7, 2017
A sketch of known and novel MYCN-associated miRNA networks in neuroblastomaFrancesca Megiorni, Moreno Colaiacovo, Samantha Cialfi, et al.
Journal of Cancer Research and Clinical Oncology|October 26, 2018
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell linesSimona Camero, Simona Ceccarelli, Francesca De Felice, et al.
Eclinicalmedicine|April 25, 2022
SARS-COV2 placentitis and pregnancy outcome: A multicentre experience during the Alpha and early Delta waves of coronavirus pandemic in EnglandSophie Stenton, Jo McPartland, Rajeev Shukla, et al.
Journal of Hematology & Oncology|October 8, 2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cellsFrancesca Megiorni, Giovanni Luca Gravina, Simona Camero, et al.
Frontiers in Pediatrics|August 8, 2022
Thyroid cancer in children: A multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumorsCristina Martucci, Alessandro Crocoli, Maria Debora De Pasquale, et al.
Pageof 5